|Articles|May 30, 2019
Speaking with David Van Sickle, CEO, Propeller Health
David Van Sickle, CEO, Propeller Health, talks with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event about how the digital therapeutics landscape has changed.
Advertisement
David Van Sickle, CEO, Propeller Health, talks with Pharm Exec's European Editor, Julian Upton, at the 2019 17th Annual Patient Engagement eyeforpharma Barcelona event about how the digital therapeutics landscape has changed.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
From Evidence to Access: How Real-World Data Delivers for Patients
2
Pharmaceutical Executive Daily: Tariff Uncertainty Accelerates Manufacturing Shifts
3
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase: Report
4
Burnout and Shortages Put the Blood Supply at Risk
5